These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 2488326)

  • 1. Lymphokine-activated killer lymphocytes: extramural clinical trials.
    Sniecinski IJ
    Immunol Ser; 1989; 48():59-77. PubMed ID: 2488326
    [No Abstract]   [Full Text] [Related]  

  • 2. Lymphokine-activated killer lymphocytes: biotherapeutics clinical trials.
    West WH
    Immunol Ser; 1989; 48():79-92. PubMed ID: 2488327
    [No Abstract]   [Full Text] [Related]  

  • 3. Lymphokine-activated killer lymphocytes: National Cancer Institute clinical trials.
    Clark J; Longo DL
    Immunol Ser; 1989; 48():37-58. PubMed ID: 2488325
    [No Abstract]   [Full Text] [Related]  

  • 4. Therapy with interleukin-2 and tumor-derived activated lymphocytes.
    Oldham RK
    Immunol Ser; 1994; 61():251-71. PubMed ID: 8011748
    [No Abstract]   [Full Text] [Related]  

  • 5. Lymphokine-activated killer lymphocytes: LAK and interleukin-2 in the treatment of malignancies of the central nervous system.
    Blacklock JB; Grimm EA
    Immunol Ser; 1989; 48():93-9. PubMed ID: 2488328
    [No Abstract]   [Full Text] [Related]  

  • 6. [Interleukin-2 and adoptive immunotherapy: their biological aspects and clinical application in oncology].
    Barón Saura JM; Pizarro Redondo A; Berrocal Jaime A; González Barón M
    Rev Clin Esp; 1991 May; 188(9):468-72. PubMed ID: 1896596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical/technical challenges in adoptive cellular immunotherapy: in vitro culture techniques.
    Yannelli JR; Jadus MR; Beckner S; Lacerna LV; Oldham RK
    Immunol Ser; 1989; 48():191-206. PubMed ID: 2488322
    [No Abstract]   [Full Text] [Related]  

  • 8. [Immunotherapy of malignant melanoma].
    Flageul B; Miclea JM; Bensussan A; Degos L
    Pathol Biol (Paris); 1990 Oct; 38(8):881-2. PubMed ID: 2274397
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical use of interleukin-2 in treating cancer.
    Patterson DL; Wiemann MC
    Indiana Med; 1991 Aug; 84(8):534-7. PubMed ID: 1918915
    [No Abstract]   [Full Text] [Related]  

  • 10. [Our experience with lymphocytes activated against cancer: CTL cells].
    Marcellino LR; Vinciguerra M; Marcellino MV; Sessa E
    G Chir; 1997 Oct; 18(10):605-7. PubMed ID: 9479972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adoptive cellular immunotherapy for cancer: interleukin-2 activated lymphocytes.
    Wolf JA; Grimm EA
    Curr Opin Oncol; 1989 Dec; 1(2):249-57. PubMed ID: 2489968
    [No Abstract]   [Full Text] [Related]  

  • 12. The preparation of effector cells for use in the adoptive cellular immunotherapy of human cancer.
    Yannelli JR
    J Immunol Methods; 1991 May; 139(1):1-16. PubMed ID: 2040807
    [No Abstract]   [Full Text] [Related]  

  • 13. LAK cell therapy--clinical studies and future potential.
    Marshall GD; Schwartzberg LS; Tauer KW; Lee P; Holbert JM; West WH
    Prog Clin Biol Res; 1990; 337():555-8. PubMed ID: 2191342
    [No Abstract]   [Full Text] [Related]  

  • 14. Adoptive cellular immunotherapy of cancer: future perspectives.
    Stevenson HC
    Immunol Ser; 1989; 48():229-36. PubMed ID: 2488324
    [No Abstract]   [Full Text] [Related]  

  • 15. [Adoptive immunotherapy using interleukin-2 and interleukin-2-activated lymphocytes].
    van de Loosdrecht AA; Ossenkoppele GJ; Beelen RH
    Ned Tijdschr Geneeskd; 1989 Oct; 133(40):1994-5. PubMed ID: 2812087
    [No Abstract]   [Full Text] [Related]  

  • 16. Interleukin-2: basic biology and therapeutic use.
    Williams TM; Fox KR; Kant JA
    Hematol Pathol; 1991; 5(2):45-55. PubMed ID: 1894582
    [No Abstract]   [Full Text] [Related]  

  • 17. [Adoptive immunotherapy with interleukin-2 and with interleukin-2 activated lymphocytes].
    Eggermont AM; Stoter G; Jansen RL; Bolhuis RL
    Ned Tijdschr Geneeskd; 1989 Jul; 133(28):1387-92. PubMed ID: 2677757
    [No Abstract]   [Full Text] [Related]  

  • 18. Adoptive cellular therapy.
    Urba WJ; Longo DL
    Cancer Chemother Biol Response Modif; 1990; 11():265-80. PubMed ID: 2223395
    [No Abstract]   [Full Text] [Related]  

  • 19. Tumor-derived activated cells: culture conditions and characterization.
    Maleckar JR; Friddell CS; Lewko WM; Yannelli JR; West WH; Oldham RK
    Immunol Ser; 1989; 48():159-73. PubMed ID: 2488319
    [No Abstract]   [Full Text] [Related]  

  • 20. New perspectives in immunotherapy of leukemia.
    Lotzová E
    Immunol Ser; 1994; 61():231-8. PubMed ID: 8011747
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.